These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1388697)
41. Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form. Sundaram RS; Szumlanski C; Otterness D; van Loon JA; Weinshilboum RM Drug Metab Dispos; 1989; 17(3):255-64. PubMed ID: 2568905 [TBL] [Abstract][Full Text] [Related]
42. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea. Huot P; Lévesque M; Parent A Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832 [TBL] [Abstract][Full Text] [Related]
43. Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus accumbens of the rat. Jones SR; Garris PA; Kilts CD; Wightman RM J Neurochem; 1995 Jun; 64(6):2581-9. PubMed ID: 7760038 [TBL] [Abstract][Full Text] [Related]
44. Human phenol sulfotransferase: correlation of brain and platelet activities. Young WF; Laws ER; Sharbrough FW; Weinshilboum RM J Neurochem; 1985 Apr; 44(4):1131-7. PubMed ID: 3855967 [TBL] [Abstract][Full Text] [Related]
45. Sulfate conjugation of dopamine in rat brain: regional distribution of activity and evidence for neuronal localization. Rivett AJ; Francis A; Whittemore R; Roth JA J Neurochem; 1984 May; 42(5):1444-9. PubMed ID: 6584547 [TBL] [Abstract][Full Text] [Related]
46. Glutathione-related enzymes in brain in Parkinson's disease. Sian J; Dexter DT; Lees AJ; Daniel S; Jenner P; Marsden CD Ann Neurol; 1994 Sep; 36(3):356-61. PubMed ID: 8080243 [TBL] [Abstract][Full Text] [Related]
47. Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method. Orzi F; Fornai F; Blandini F Funct Neurol; 2000; 15(4):269-76. PubMed ID: 11213530 [No Abstract] [Full Text] [Related]
48. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831 [TBL] [Abstract][Full Text] [Related]
49. [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy. Bokobza B; Ruberg M; Scatton B; Javoy-Agid F; Agid Y Eur J Pharmacol; 1984 Mar; 99(2-3):167-75. PubMed ID: 6734727 [TBL] [Abstract][Full Text] [Related]
50. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride. Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051 [TBL] [Abstract][Full Text] [Related]
51. Brain acetylcholinesterase in Parkinson's disease. Rinne UK; Riekkinen P; Sonninen V; Laaksonen H Acta Neurol Scand; 1973; 49(2):215-26. PubMed ID: 4718190 [No Abstract] [Full Text] [Related]
52. Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset. Gnanalingham KK; Milkowski NA; Smith LA; Hunter AJ; Jenner P; Marsden CD Eur J Pharmacol; 1995 Apr; 277(2-3):235-41. PubMed ID: 7493614 [TBL] [Abstract][Full Text] [Related]
53. Human liver phenol sulfotransferase: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form. Campbell NR; Van Loon JA; Weinshilboum RM Biochem Pharmacol; 1987 May; 36(9):1435-46. PubMed ID: 3472524 [TBL] [Abstract][Full Text] [Related]
54. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation. Tong J; Ang LC; Williams B; Furukawa Y; Fitzmaurice P; Guttman M; Boileau I; Hornykiewicz O; Kish SJ Neurobiol Dis; 2015 Oct; 82():243-253. PubMed ID: 26102022 [TBL] [Abstract][Full Text] [Related]